24-07-2026 23:37 via medpagetoday.com

FDA Approves Branded Bevacizumab for Wet AMD

(MedPage Today) -- The FDA approved the first formulation of bevacizumab specifically for the treatment of neovascular (wet) age-related macular degeneration (nAMD), Outlook Therapeutics announced on Friday.
The approval of bevacizumab-vikg (Lytenava...
Read more »

Medical Industry news



Multistate Salmonella Outbreak Tied to Eggs Has Sickened 98 People
The Baby in the NICU Is Not the Only One Suffering
1,300 Dead in Outbreak; Cyclospora Response 'Mismanaged'? GLP-1 Access in Medicaid
'What You're Seeing Here Is Pure Censorship': What We Heard This Week
AMA President: It's Time to Lift Limits on Physician-Owned Hospitals
GLP-1s and Alcohol Use Disorder; No Luck With Gonorrhea Vaccine
Restrictions on Physician-Owned Hospitals are Justified
This Year's Ebola Outbreak Has Spread Faster Than the Worst on Record
Study Links GLP-1s to Lower Risk of Fragility Fractures in Diabetes Patients
Branded Bevacizumab Approved for Wet AMD
FDA Panel Finds a Peptide It Doesn't Like
New Avacopan Analysis Sent to FDA After Data Manipulation Allegations
FDA Gets New Avacopan Analysis After Alleging Data Manipulation
FDA Approves Tylenol With Naproxen Combination
Desktop versie